Safety and Efficacy Study of BRIMOCHOL™, BRIMOCHOL™ F, and Carbachol in Subjects With Emmetropic Phakic and Pseudophakic Presbyopia

Completed · Phase 2

Conditions studied: Presbyopia

In brief

Safety and Efficacy Study of BRIMOCHOL™ vs. BRIMOCHOL™ F vs. Carbachol Monotherapy Topical Ophthalmic Solutions in Subjects with Emmetropic Phakic and Pseudophakic Presbyopia

Key facts

Study ID

NCT04774237

Run by

Visus Therapeutics

People needed

18

Starts

2021-03-24

Expected to finish

2021-10-19

Last updated by the study team

2026-03-27

Who can join

Age: 45 and older, up to 80. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• Male or female in good general health
• Must have presbyopia

You may not qualify if…

• History of allergic reaction to the study drug or any of its components
• Any disease or medical condition that, in the opinion of the Investigator, would prevent the subject from participating in the study or might confound study results

Where it is running

• Global Research Management, Inc. — Glendale, California, United States
• Eye Research Foundation — Newport Beach, California, United States
• Total Eye Care, PA — Memphis, Tennessee, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.